Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Phosphohistone H3 (pHH3) is a prognostic and epithelial to mesenchymal transition marker in diffuse gliomas.

Zhu P, Zhang CB, Yang P, Chen J, Liu YQ, Hu HM, Huang H, Bao ZS, Zhang W, Kong WJ, Jiang T.

Oncotarget. 2016 Jul 19;7(29):45005-45014. doi: 10.18632/oncotarget.7154.

2.

An Appraisal of Proliferation and Apoptotic Markers in Papillary Thyroid Carcinoma: An Automated Analysis.

Lamba Saini M, Bouzin C, Weynand B, Marbaix E.

PLoS One. 2016 Feb 10;11(2):e0148656. doi: 10.1371/journal.pone.0148656. eCollection 2016.

3.

Wnt/β-catenin and sonic hedgehog pathways interact in the regulation of the development of the dorsal mesenchymal protrusion.

Briggs LE, Burns TA, Lockhart MM, Phelps AL, Van den Hoff MJ, Wessels A.

Dev Dyn. 2016 Feb;245(2):103-13. doi: 10.1002/dvdy.24339. Epub 2015 Dec 29.

4.

Value of counting positive PHH3 cells in the diagnosis of uterine smooth muscle tumors.

Pang SJ, Li CC, Shen Y, Liu YZ, Shi YQ, Liu YX.

Int J Clin Exp Pathol. 2015 May 1;8(5):4418-26. eCollection 2015.

5.

Phosphohistone H3: implications for clinical practice and risk assessment in meningioma.

Olar A.

Neuro Oncol. 2015 May;17(5):631-3. doi: 10.1093/neuonc/nov047. Epub 2015 Mar 25. No abstract available.

6.

PHH3 as an Ancillary Mitotic Marker in Gastrointestinal Stromal Tumors.

Shin Y, Hyeon J, Lee B, Ha SY, Hong ME, Do IG, Kim KM.

J Pathol Transl Med. 2015 Jan;49(1):23-9. doi: 10.4132/jptm.2014.10.08. Epub 2015 Jan 15.

7.

Pathology and genetics of diffuse gliomas in adults.

Komori T.

Neurol Med Chir (Tokyo). 2015;55(1):28-37. doi: 10.2176/nmc.ra.2014-0229. Epub 2014 Dec 20. Review.

8.

Pathology and molecular genetics of meningioma: recent advances.

Shibuya M.

Neurol Med Chir (Tokyo). 2015;55(1):14-27. doi: 10.2176/nmc.ra.2014-0233. Epub 2014 Dec 20. Review.

9.

Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.

Duregon E, Cassenti A, Pittaro A, Ventura L, Senetta R, Rudà R, Cassoni P.

Neuro Oncol. 2015 May;17(5):663-9. doi: 10.1093/neuonc/nov002. Epub 2015 Feb 1.

10.

Cell cycle kinetic analysis of colorectal neoplasms using a new automated immunohistochemistry-based cell cycle detection method.

Tomono A, Itoh T, Yanagita E, Imagawa N, Kakeji Y.

Medicine (Baltimore). 2015 Jan;94(4):e501. doi: 10.1097/MD.0000000000000501.

11.

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

Olar A, Wani KM, Sulman EP, Mansouri A, Zadeh G, Wilson CD, DeMonte F, Fuller GN, Aldape KD.

Brain Pathol. 2015 May;25(3):266-75. doi: 10.1111/bpa.12174. Epub 2014 Oct 29.

12.

Immunohistochemical expression of hormone receptors in melanoma of pregnant women, nonpregnant women, and men.

Zhou JH, Kim KB, Myers JN, Fox PS, Ning J, Bassett RL, Hasanein H, Prieto VG.

Am J Dermatopathol. 2014 Jan;36(1):74-9. doi: 10.1097/DAD.0b013e3182914c64.

13.

Level of phosphohistone H3 among various types of human cancers.

Sun A, Zhou W, Lunceford J, Strack P, Dauffenbach LM, Kerfoot CA.

BMJ Open. 2012 Oct 12;2(5). pii: e001071. doi: 10.1136/bmjopen-2012-001071. Print 2012.

14.

The histopathological spectrum of human meningiomas.

Backer-Grøndahl T, Moen BH, Torp SH.

Int J Clin Exp Pathol. 2012;5(3):231-42. Epub 2012 Mar 25.

15.

Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas.

Hightower E, Cabanillas ME, Fuller GN, McCutcheon IE, Hess KR, Shah K, Waguespack SG, Corley LJ, Devin JK.

Pituitary. 2012 Dec;15(4):556-61. doi: 10.1007/s11102-011-0367-3.

16.

The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas.

Aune G, Stunes AK, Tingulstad S, Salvesen O, Syversen U, Torp SH.

Int J Clin Exp Pathol. 2011 Jun 20;4(5):444-53. Epub 2011 Jun 11.

17.

Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas--an assessment of 3 new variables in predicting clinical outcome.

Margraf LR, Gargan L, Butt Y, Raghunathan N, Bowers DC.

Neuro Oncol. 2011 Jul;13(7):767-74. doi: 10.1093/neuonc/nor041. Epub 2011 Jun 8.

19.

Molecular architecture of myelinated peripheral nerves is supported by calorie restriction with aging.

Rangaraju S, Hankins D, Madorsky I, Madorsky E, Lee WH, Carter CS, Leeuwenburgh C, Notterpek L.

Aging Cell. 2009 Apr;8(2):178-91. doi: 10.1111/j.1474-9726.2009.00460.x. Epub 2009 Feb 23.

20.

Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation.

Blumberg H, Dinh H, Trueblood ES, Pretorius J, Kugler D, Weng N, Kanaly ST, Towne JE, Willis CR, Kuechle MK, Sims JE, Peschon JJ.

J Exp Med. 2007 Oct 29;204(11):2603-14. Epub 2007 Oct 1.

Supplemental Content

Support Center